Risk of non-melanoma skin cancer in patients with a history of NMSC with the use of immunosuppressant and biologic agents in autoimmune disease

IMPORTANCE: Immune dysfunction underlies the pathogenesis of rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). Immunosuppressive therapy is the standard of care for these diseases. Both immune dysfunction and therapy-related immunosuppression can inhibit cancer-related immune surveilla...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Dermatol
Main Authors: Scott, Frank I, Mamtani, Ronac, Brensinger, Colleen M, Haynes, Kevin, Chiesa-Fuxench, Zelma C, Zhang, Jie, Chen, Lang, Xie, Fenglong, Yun, Huifeng, Osterman, Mark T., Beukelman, Timothy, Margolis, David J., Curtis, Jeffrey R, Lewis, James D
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935268/
https://ncbi.nlm.nih.gov/pubmed/26510126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2015.3029
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares